Latency-reversing agents: where are we now?

Combining LRAs with immune modulators represents a promising strategy to expose viral reservoirs to immune clearance and advance toward durable, scalable ART-free remission.

Authors

Institutions

Publication Details

Journal
Current Opinion in HIV and AIDS
Published
2025-11-10
DOI
https://doi.org/10.1097/coh.0000000000000993
Citations
3
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
2.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Latency-reversing agents: where are we now?

Maryam Bendoumou, Carine Van Lint
3 citations
Current Opinion in HIV and AIDS
Immunotherapy and Immune Responses
2.39
article

Latency-reversing agents: where are we now?

Maryam Bendoumou, Carine Van Lint
article en
3 citations

Abstract

Combining LRAs with immune modulators represents a promising strategy to expose viral reservoirs to immune clearance and advance toward durable, scalable ART-free remission.

Current Opinion in HIV and AIDSVol. 21(1)
Université Libre de Bruxelles (BE)
Openalex Percentile: Top 9%
Immunotherapy and Immune Responses
2.39
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Latency-reversing agents: where are we now? — Maryam Bendoumou, Carine Van Lint · Current Opinion in HIV and AIDS (2025) | TGRS Research Map | TGRS